Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Core Insights - Profusa, Inc. has signed a Letter of Intent to establish a distribution agreement in Spain for its Lumee Oxygen platform, partnering with Dismeval, S.L. [1][2] - The partnership aims to enhance Profusa's distribution infrastructure in Europe, targeting a global addressable market exceeding $10.5 billion for its tissue oxygen technology across three medical indications [2][3] - Profusa's technology addresses a significant clinical need in Europe, with over 300,000 endovascular procedures performed annually [2] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors that provide continuous, actionable medical data [3] - The company aims to deliver long-lasting, injectable, and affordable biosensors, creating a personalized biochemical signature for reliable clinical use [3]